policy

This EMCDDA paper introduces the European Union’s approach to drug supply reduction, explaining how policies, structures, and actions are designed to disrupt drug markets and limit the availability of illicit substances. It highlights the...

This report takes an important step towards understanding how European countries fund efforts to tackle illicit drugs. By examining public spending on supply reduction measures, it highlights how resources are allocated, the gaps in...

The International Drug Policy Academy (IDPA), established by the Council of Europe's Pompidou Group, is dedicated to enhancing the capabilities of professionals involved in drug policy and addiction services. With over 50 years of...

Synthetic drugs have become a significant global public health concern, and particularly in Nigeria. More worrisome is the level of ingenuity associated with synthetic drugs, the speed of production, difficulties in identification and the...

BACKGROUND: Coolmine’s implementation of quality standards involves a period of change management, strategic planning, and national policy development. METHODS: A narrative case study focusing on national policy and internal strategic...

INTRODUCTION: The Cyprus National Addictions Authority (NAAC) is the main coordinating body for all matters related to licit and illicit substances as well as pathological gambling in Cyprus and it is responsible, inter alia, for the...

BACKGROUND: In the field of harm reduction (HR), an established quality assurance system with implemented quality standards is rather rare in practice. Together with limited evidence in this area, this leads to an imbalance in the basic...